Neonatal outcomes of late-preterm birth associated or not with intrauterine growth restriction

Cristiane Ortigosa Rocha1, Roberto Eduardo Bittar, Marcelo Zugaib

  • 1Department of Obstetrics, University of Sao Paulo, Av. dr Eneas de Carvalho Aguiar, 945, Cerqueira Cesar, Sao Paulo SP, cep 05412-002, Brazil.

Insights

Late-preterm infants with intrauterine growth restriction (IUGR) face higher risks for neonatal complications, including longer hospital stays and hypoglycemia, compared to appropriate-for-gestational-age (AGA) infants. However, mortality rates were similar in this study.

Area of Science:

  • Neonatology
  • Perinatology
  • Pediatric Research

Background:

  • Late-preterm infants (34-36 6/7 weeks GA) are a vulnerable population.
  • Intrauterine growth restriction (IUGR) is a significant concern in fetal development.
  • Understanding neonatal outcomes for IUGR infants is crucial for clinical management.

Purpose of the Study:

  • To compare neonatal morbidity and mortality between late-preterm infants with IUGR and appropriate-for-gestational-age (AGA) infants.
  • To identify specific complications associated with IUGR in the late-preterm period.

Main Methods:

  • Retrospective analysis of 50 singleton pregnancies with IUGR and 36 singleton pregnancies with AGA infants.
  • Infants were delivered between 34 and 36 6/7 weeks of gestational age (GA).
  • Statistical comparison using chi-squared analysis, Fisher's exact test, and Kruskal-Wallis test.

Main Results:

  • IUGR infants experienced longer nursery stays and neonatal intensive care unit (NICU) hospitalizations.
  • Higher risk of intraventricular hemorrhage and hypoglycemia observed in IUGR infants.
  • No significant differences in transient tachypnea of the newborn, apnea, sepsis, thrombocytopenia, or hyperbilirubinemia.

Conclusions:

  • Late-preterm IUGR infants exhibit a significantly higher risk of neonatal complications compared to late-preterm AGA infants.
  • While mortality was not increased, specific morbidities warrant closer monitoring and management.
  • Further research into optimizing care for this high-risk group is recommended.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...